Denali Therapeutics Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC DNLI

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,200,475

Value ($000)

19,820

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	19,820	0.0%	1,200,475	12/31/2025
2025 Q3	11/10/2025	16,718	0.0%	1,151,384	9/30/2025
2025 Q2	8/12/2025	14,774	0.0%	1,056,019	6/30/2025
2025 Q1	9/15/2025	13,730	0.0%	1,009,896	3/31/2025
2024 Q4	2/6/2025	20,960	0.0%	1,028,462	12/31/2024
2024 Q3	11/12/2024	29,591	0.0%	1,015,810	9/30/2024
2024 Q2	8/12/2024	24,597	0.0%	1,059,304	6/30/2024
2024 Q1	5/9/2024	21,363	0.0%	1,041,059	3/31/2024
2023 Q4	2/6/2024	21,610	0.0%	1,006,997	12/31/2023
2023 Q3	11/8/2023	20,239	0.0%	981,059	9/30/2023
2023 Q2	8/10/2023	25,604	0.0%	867,631	6/30/2023
2023 Q1	5/12/2023	19,269	0.0%	836,328	3/31/2023
2022 Q4	2/13/2023	23,268	0.0%	836,673	12/31/2022
2022 Q3	11/14/2022	22,431	0.0%	730,880	9/30/2022
2022 Q2	8/15/2022	21,530	0.0%	731,522	6/30/2022
2022 Q1	5/13/2022	22,656	0.0%	704,251	3/31/2022
2021 Q4	2/11/2022	31,987	0.0%	717,190	12/31/2021
2021 Q3	11/16/2021	35,505	0.0%	703,752	9/30/2021
2021 Q2	8/16/2021	50,220	0.0%	640,234	6/30/2021
2021 Q1	5/17/2021	32,291	0.0%	565,516	3/31/2021
2020 Q4	2/16/2021	41,311	0.0%	493,198	12/31/2020
2020 Q3	11/13/2020	17,430	0.0%	486,440	9/30/2020
2020 Q2	8/20/2020	11,395	0.0%	471,246	6/30/2020
2020 Q1	5/15/2020	7,331	0.0%	418,672	3/31/2020
2019 Q4	2/7/2020	6,524	0.0%	374,478	12/31/2019